| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |